These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6415326)

  • 1. Studies to increase the antitumor activity of 1-(tetrahydro-2-furanyl)-5-fluorouracil and its metabolic aspects by combined administration with L-cysteine.
    Kawabata N; Sugiyama S; Kuwamura T; Satoh T; Kitagawa H
    Jpn J Pharmacol; 1983 Aug; 33(4):735-47. PubMed ID: 6415326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism, antitumor activity, and acute toxicity of 5-fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione by oral administration to animals.
    Fujii S; Nakamura Y; Takeda S; Morita K; Sato T; Marunaka T; Kawaguchi Y; Unemi N
    Gan; 1980 Feb; 71(1):30-44. PubMed ID: 6769737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-cysteine on plasma concentration and urinary excretion of 1-(tetrahydro-2-furanyl)-5-fluorouracil metabolites.
    Kawabata N; Yano K; Ohno H; Nakashima T
    Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):1068-71. PubMed ID: 1893491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans.
    Benvenuto JA; Lu K; Hall SW; Benjamin RS; Loo TL
    Cancer Res; 1978 Nov; 38(11 Pt 1):3867-70. PubMed ID: 359130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the chemotherapeutic action of tegafur against solid adenocarcinoma 755 by combination with L-cystine.
    Iigo M; Hoshi A; Kitagawa H
    J Cancer Res Clin Oncol; 1986; 111(3):187-90. PubMed ID: 3090050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P-450-dependent oxidative cleavage of 1-(tetrahydro-2-furanyl)-5-fluorouracil to 5-fluorouracil.
    Kawata S; Minami Y; Tarui S; Marunaka T; Okamoto M; Yamano T
    Jpn J Pharmacol; 1984 Sep; 36(1):43-9. PubMed ID: 6438379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of L-cysteine on distribution volume of 1-(tetrahydro-2-furanyl)-5-fluorouracil.
    Kawabata N; Yano K; Ohno H; Nakashima T
    Jpn J Pharmacol; 1990 Dec; 54(4):487-90. PubMed ID: 2087012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on antitumor agents, 2. Syntheses and antitumor activities of 1-(tetrahydro-2-furanyl)-5-fluorouracil and 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil.
    Yasumoto M; Yamawaki I; Marunaka T; Hashimoto S
    J Med Chem; 1978 Aug; 21(8):738-41. PubMed ID: 357721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil in mice.
    Fujimoto S; Ishigami H; Minami T; Miyazaki M; Itoh K; Kimura K
    J Natl Cancer Inst; 1979 Aug; 63(2):465-8. PubMed ID: 379401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil co-administered orally to tumor-bearing rats.
    Kawaguchi Y; Nagayama S; Masuda H; Yasuda A
    Gan; 1980 Dec; 71(6):889-99. PubMed ID: 6791982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of antitumor agents. 1. Resolution of racemic 1-(tetrahydro-2-furanyl)-k-fluorouracil into the R and S isomers and examination of the biological activities of the isomers.
    Yasumoto M; Moriyama A; Unemi N; Hashimoto S; Suzue T
    J Med Chem; 1977 Dec; 20(12):1592-4. PubMed ID: 338900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxylated metabolies of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in rats and rabbits.
    Wu AT; Au JL; Sadée W
    Cancer Res; 1978 Jan; 38(1):210-4. PubMed ID: 338145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats.
    Yoshisue K; Masuda H; Matsushima E; Ikeda K; Nagayama S; Kawaguchi Y
    Drug Metab Dispos; 2000 Oct; 28(10):1162-7. PubMed ID: 10997934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of metabolites of 1-(tetrahydro-2-furanyl)-5-fluorouracil (FT-207) formed in vitro by rat liver microsomes.
    Marunaka T; Minami Y; Umeno Y; Yasuda A; Sato T; Fujii S
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1795-80. PubMed ID: 6773678
    [No Abstract]   [Full Text] [Related]  

  • 16. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
    Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents.
    Fujii S; Kitano S; Ikenaka K; Shirasaka T
    Gan; 1979 Apr; 70(2):209-14. PubMed ID: 381088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro.
    Ikeda K; Yoshisue K; Matsushima E; Nagayama S; Kobayashi K; Tyson CA; Chiba K; Kawaguchi Y
    Clin Cancer Res; 2000 Nov; 6(11):4409-15. PubMed ID: 11106261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-fluorouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats.
    Yoshisue K; Nagayama S; Shindo T; Kawaguchi Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1166-75. PubMed ID: 11356943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) to 5-fluorouracil by soluble enzymes.
    El Sayed YM; Sadée W
    Cancer Res; 1983 Sep; 43(9):4039-44. PubMed ID: 6409396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.